Research Article
Serum Interleukin-23 in Polish Patients with Systemic Lupus Erythematosus: Association with Lupus Nephritis, Obesity, and Peripheral Vascular Disease
Table 8
The multivariate stepwise analysis for serum levels of IL-23 > 3.1 pg/mL and IL-23 > 0.0 pg/mL.
| Covariates | Serum IL-23 > 3.1 pg/mL | Serum IL-23 > 0.0 pg/mL | OR (95% CI) | | OR (95% CI) | |
| Atherosclerotic plaque in cfa | 4.27 (1.08–16.89) | 0.038 | 12.67 (1.41–113.84) | 0.023 | Obesity | 4.21 (1.40–12.67) | 0.011 | 2.98 (0.84–10.61) | 0.091 | Anti-SS-B/La IgG | 4.14 (1.14–15.07) | 0.031 | 15.43 (1.73–137.25) | 0.014 | Lupus nephritis | NS | NS | 3.69 (1.11–12.22) | 0.033 | Anti-phosphatidylethanolamine IgG | NS | NS | 11.06 (1.24–98.65) | 0.031 |
|
|
Cfa: common femoral artery; NS: nonsignificant. OR and adjusted for sex and age.
|